Daiken Medical Co., Ltd. (TYO:7775)
501.00
+1.00 (0.20%)
Mar 12, 2025, 3:30 PM JST
Daiken Medical Revenue
Daiken Medical had revenue of 2.75B JPY in the quarter ending December 31, 2024, with 6.58% growth. This brings the company's revenue in the last twelve months to 10.01B, up 3.76% year-over-year. In the fiscal year ending March 31, 2024, Daiken Medical had annual revenue of 9.75B with 6.71% growth.
Revenue (ttm)
10.01B
Revenue Growth
+3.76%
P/S Ratio
1.44
Revenue / Employee
57.20M
Employees
175
Market Cap
14.42B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 9.75B | 613.00M | 6.71% |
Mar 31, 2023 | 9.14B | 597.00M | 6.99% |
Mar 31, 2022 | 8.54B | 679.00M | 8.64% |
Mar 31, 2021 | 7.86B | -662.00M | -7.77% |
Mar 31, 2020 | 8.52B | 117.00M | 1.39% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,170.61B |
Takeda Pharmaceutical Company | 4,579.02B |
Daiichi Sankyo Company | 1,795.99B |
HOYA Corporation | 837.44B |
Otsuka Holdings | 2,329.86B |
Terumo | 1,011.15B |
Astellas Pharma | 1,867.63B |
Olympus | 993.33B |